SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-035372
Filing Date
2022-12-14
Accepted
2022-12-14 06:45:53
Documents
16
Period of Report
2022-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46495
2 ex10-1.htm EX-10.1 468118
3 ex99-1.htm EX-99.1 76512
4 ex99-1_001.jpg GRAPHIC 3645
  Complete submission text file 0001493152-22-035372.txt   898382

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrow-20221213.xsd EX-101.SCH 3941
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrow-20221213_def.xml EX-101.DEF 27017
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrow-20221213_lab.xml EX-101.LAB 37280
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrow-20221213_pre.xml EX-101.PRE 25638
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5579
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 221461117
SIC: 2834 Pharmaceutical Preparations